To further investigate how anti-IL-1β and anti-PD-1 treatment modulates the tumor microenvironment, we performed flow cytometry analysis of tumor infiltrating leukocytes (TILs) from primary orthotopic tumors for both the KPC-4545 and the KPC-3403 model. Here, IL1B is linked to neoplasm.